Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes.

Rickels MR, Naji A, Teff KL.

J Clin Endocrinol Metab. 2006 Jun;91(6):2138-44. Epub 2006 Mar 28.

PMID:
16569741
2.

Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures.

Rickels MR, Kong SM, Fuller C, Dalton-Bakes C, Ferguson JF, Reilly MP, Teff KL, Naji A.

Am J Physiol Endocrinol Metab. 2014 May 15;306(10):E1217-24. doi: 10.1152/ajpendo.00667.2013. Epub 2014 Apr 1.

3.

Improvement in insulin sensitivity after human islet transplantation for type 1 diabetes.

Rickels MR, Kong SM, Fuller C, Dalton-Bakes C, Ferguson JF, Reilly MP, Teff KL, Naji A.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1780-5. doi: 10.1210/jc.2013-1764. Epub 2013 Oct 1.

4.

Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients.

Rickels MR, Schutta MH, Mueller R, Kapoor S, Markmann JF, Naji A, Teff KL.

J Clin Endocrinol Metab. 2007 Mar;92(3):873-9. Epub 2006 Dec 27.

PMID:
17192287
5.

Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.

Diabetes Care. 2006 May;29(5):1031-8.

PMID:
16644633
6.

Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: preliminary results.

Hirsch D, Odorico J, Radke N, Hanson M, Danobeitia JS, Hullett D, Alejandro R, Ricordi C, Fernandez LA.

Diabetes Obes Metab. 2010 Nov;12(11):994-1003. doi: 10.1111/j.1463-1326.2010.01290.x.

PMID:
20880346
7.

Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes.

Rickels MR, Schutta MH, Mueller R, Markmann JF, Barker CF, Naji A, Teff KL.

Diabetes. 2005 Nov;54(11):3205-11.

8.

Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.

Rickels MR, Mueller R, Markmann JF, Naji A.

J Clin Endocrinol Metab. 2009 Jan;94(1):181-9. doi: 10.1210/jc.2008-1806. Epub 2008 Oct 28.

9.

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.

Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C.

Transplantation. 2002 Dec 27;74(12):1761-6.

PMID:
12499894
10.

Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes.

Rickels MR, Peleckis AJ, Markmann E, Dalton-Bakes C, Kong SM, Teff KL, Naji A.

J Clin Endocrinol Metab. 2016 Nov;101(11):4421-4430. Epub 2016 Aug 29.

PMID:
27571180
11.

Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women.

Chow CC, Periwal V, Csako G, Ricks M, Courville AB, Miller BV 3rd, Vega GL, Sumner AE.

J Clin Endocrinol Metab. 2011 Aug;96(8):2456-63. doi: 10.1210/jc.2011-0532. Epub 2011 May 18.

12.

Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients.

Luzi L, Groop LC, Perseghin G, Taskinen MR, Hilden H, Bianchi E, Terruzzi I, Dodesini AR, Di Carlo V, Pozza G.

Diabetes. 1996 Mar;45(3):354-60.

PMID:
8593942
13.

Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.

Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM.

Diabetes. 2001 Apr;50(4):710-9.

14.

Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy.

Soleimanpour SA, Hirshberg B, Bunnell DJ, Sumner AE, Ader M, Remaley AT, Rother KI, Rickels MR, Harlan DM.

Cell Transplant. 2012;21(6):1297-304. doi: 10.3727/096368911X603620. Epub 2011 Nov 11.

15.

A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

Diabetes. 2003 Oct;52(10):2461-74.

16.

Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation.

Graham ML, Bellin MD, Papas KK, Hering BJ, Schuurman HJ.

Xenotransplantation. 2011 Nov-Dec;18(6):328-42. doi: 10.1111/j.1399-3089.2011.00676.x.

PMID:
22168140
18.

Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.

Christiansen E, Vestergaard H, Tibell A, Hother-Nielsen O, Holst JJ, Pedersen O, Madsbad S.

Diabetes. 1996 Sep;45(9):1267-75.

PMID:
8772733
19.

Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.

Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA.

Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1360-8.

Supplemental Content

Support Center